Comparison of L-758,298, a prodrug for the selective neurokinin-1 antagonist, L-754,030, with ondansetron for the prevention of cisplatin-induced emesis

Autor: Cocquyt, V, Van Belle, S ^*, Reinhardt, R.R, Decramer, M.L.A, O'Brien, M, Schellens, J.H.M, Borms, M, Verbeke, L, Van Aelst, F, De Smet, M, Carides, A.D, Eldridge, K, Gertz, B.J

Publikováno v: In European Journal of Cancer May 2001 37(7):835-842

EUROASPIRE III. Management of cardiovascular risk factors in asymptomatic high-risk patients in general practice: cross-sectional survey in 12 European countries

Autor: Kotseva, K., Wood D, De Backer G, De Bacquer D, Pyörälä K, Reiner, Željko, Keil U, EUROASPIRE Study Group. Collaborators: Pyörälä K, Ambrosio GB, Cokkinos D, Deckers JW, Dzerve V, Fraz Z, Gaita D, Gotcheva N, Graham I, Kotseva K, Laucevicius A, Lehto S, McGregor K, Nicolaides P, Oganov R, Ostör E, Pajak A, Simon J, Tokgözoğlu L, De Velasco J, Jenning C, Xenikaki D, Winnicki J, Manini M, Bramley C, Boulle C, Taylor C, Sundvall J, Lund L, De Sutter J, Piessens V, Van den Abbeele H, Dierickx E, Muylaert P, Present L, Braeckman M, Bruggeman H, Debackere P, Heytens S, Deleu K, Behaeghe P, Van De Wiele J, Van Aelst F, Taragola H, Spenninck E, Verkinderen B, Van Baeveghem S, De Waele B, De Waele C, Calis B, Schiettecatte V, Vermaercke C, Willems S, Van Imschoot K, De Vriese M, Maudens P, Maudens F, Georgiev B, Kastamanov R, Toneva K, Pavlov T, Stoev I, Alexandrov A, Miladinov A, Valterova A, Bergman-Marković, Biserka, Vinter-Repalust, Nevenka, Cerovečki Nekić, Venija, Soldo, Dragan, Petriček, Goranka, Ožvačić Adžić, Zlata, Marijić Gordana, Saloranta P, Savolainen J, Helminen EE, Heidrich J, Prugger C, Wellmann J, Neiteler G, Kalic M, Siebert E, Brand-Herrmann SM, Telgmann R, Barth F, Berger U, Briefs HJ, Degener L, Friedewald W, Heinemann-Vechtel O, Hüning U, Kalbfleisch C, Krösmann M, Neugebauer U, Noack KH, Richter-Millers B, Schuster A, Wahle K, Vanuzzo D, Mirolo R, Pilotto L, Zamaro G, Adinolfi V, Da Porto M, Gubiani M, Canciani L, Hansone S, Gozite A, Liepa L, Veze I, Putane L, Ecina V, Aija Rubine I, Rozkova N, Bricina N, Erglis A, Kawecka-Jaszcz K, Wolfshaut-Wolak R, Jankowski P, Windak A, Krzysztoń J, Makowiec-Dyrda M, Giza B, Sadek-Ratajewicz J, Sobalski T, Korman, Tomislav, Pop M, Buzulica C, Cicala C, Nicoara M, Zarici I, Iurciuc M, Iurciuc S, Roman C, Gavruta M, Breteanu L, Avram CA, Sarau CA, Avram C, Craciun L, Fras Z, Fras-Stefan T, Dovc M, Celan-Lucu B, Kralj S, Jurkovic G, Fonda A, Bercic MM, Maiques A, Mendez G, Buigues C, Montero N, Amoraga A, Bonet Y, Cuevas R, Torres Y, De Vries H, Koul B, Fellowes D, Sleight C, Purwar R, Harrison M, Saini S, Walton I, Thomas S, Igbanoi J, Bello F, Elgamel V, Kudyba M.

Objective was to determine whether the 2003 Joint European Societies' guidelines on cardiovascular disease prevention in people at high cardiovascular risk have been followed in general practice. Design was Cross-sectional survey. The EUROASPIRE surv

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::21568f7dbc0e59ca5931a120c8d6aa5a
https://doi.org/10.1097/hjr.0b013e3283383f30

772 Which factors predict overall survival in metastatic castration-resistant prostate cancer patients treated with abiraterone acetate post-docetaxel?

Autor: Van Praet, C., Rottey, S., Van Hende, F., Pelgrims, G., Demey, W., Van Aelst, F., Wynendaele, W., Gil, T., Schatteman, P., Filleul, B., Schallier, D., Machiels, J-P., Schrijvers, D., Everaert, E., D'Hondt, L., Werbrouck, P., Vermeij, J., Mebis, J., Clausse, M., Rasschaert, M., Van Erps, J., Verheezen, J., Van Haverbeke, J., Goeminne, J-C., Lumen, N.

Publikováno v: In European Urology Supplements March 2016 15(3):e772-e772

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.